FUT8 reprograms glycolytic metabolism to promote PKM2 lactylation and drive clear cell renal cell carcinoma progression.
Saved in:
| Title: | FUT8 reprograms glycolytic metabolism to promote PKM2 lactylation and drive clear cell renal cell carcinoma progression. |
|---|---|
| Authors: | Guo Z; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.; The First Affiliated Hospital, Shenzhen University; Shenzhen Second People's Hospital; Medical Innovation Technology Transformation Center of Shenzhen Second People's Hospital, Shenzhen, China., Jiang H; The First Affiliated Hospital, Shenzhen University; Shenzhen Second People's Hospital; Medical Innovation Technology Transformation Center of Shenzhen Second People's Hospital, Shenzhen, China.; Guangxi University of Chinese Medicine, Nanning, China., Wang X; The Third Affiliated Hospital of Anhui Medical University (The First People's Hospital of Hefei), Hefei, China., Xuan K; The First Affiliated Hospital, Shenzhen University; Shenzhen Second People's Hospital; Medical Innovation Technology Transformation Center of Shenzhen Second People's Hospital, Shenzhen, China., Zhong H; Department of Oncology, Ji'an Central Hospital, Ji'an, China., Liu C; Department of Applied Biology and Chemical Technology, Food Safety and Technology Research Centre, and Research Centre for Chinese Medicine Innovation, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR, China., Zhang M; The First Affiliated Hospital, Shenzhen University; Shenzhen Second People's Hospital; Medical Innovation Technology Transformation Center of Shenzhen Second People's Hospital, Shenzhen, China., Li Z; The First Affiliated Hospital, Shenzhen University; Shenzhen Second People's Hospital; Medical Innovation Technology Transformation Center of Shenzhen Second People's Hospital, Shenzhen, China. liz_hichao@126.com., Huang W; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China. hwrpony@szu.edu.cn.; The First Affiliated Hospital, Shenzhen University; Shenzhen Second People's Hospital; Medical Innovation Technology Transformation Center of Shenzhen Second People's Hospital, Shenzhen, China. hwrpony@szu.edu.cn.; State Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China. hwrpony@szu.edu.cn.; Guangdong Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, Shenzhen, China. hwrpony@szu.edu.cn.; GuangDong Engineering Technology Research Center for Clinical Application Of Cancer Genome, Shenzhen, China. hwrpony@szu.edu.cn., Sun Y; State Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China. sunyangyang06@163.com. |
| Source: | Cell death discovery [Cell Death Discov] 2026 Mar 19; Vol. 12 (1). Date of Electronic Publication: 2026 Mar 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101665035 Publication Model: Electronic Cited Medium: Print ISSN: 2058-7716 (Print) Linking ISSN: 20587716 NLM ISO Abbreviation: Cell Death Discov Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2058-7716 |
|---|---|
| DOI: | 10.1038/s41420-026-03013-1 |
